C O M M U N I C A T I O N S
Scheme 2. Asymmetric Opening of Episulfonium Ionsa
(2) (a) Llewellyn, D. B.; Adamson, D.; Arndtsen, B. A. Org. Lett. 2000, 2,
4165. For follow-up research, see:(b) Llewellyn, D. B.; Arndtsen, B. A.
Tetrahedron: Asymmetry 2005, 16, 1789. Another study: (c) Dorta, R.;
Shimon, L.; Milstein, D. J. Organomet. Chem. 2004, 689, 751.
(3) (a) Hamilton, G. L.; Kang, E. J.; Mba, M.; Toste, F. D. Science 2007, 317,
496. (b) Mukherjee, S.; List, B. J. Am. Chem. Soc. 2007, 129, 11336.
(4) For examples of chiral Brønsted acids used in cooperation with transition
metals, see:(a) Komanduri, V.; Krische, M. J. J. Am. Chem. Soc. 2006,
128, 16448. (b) Rueping, M.; Antonchick, A. P.; Brinkmann, C. Angew.
Chem., Int. Ed. 2007, 46, 6903.
(5) (a) Mayer, S.; List, B. Angew. Chem., Int. Ed. 2006, 45, 4193. (b) Martin,
N. J. A.; List, B. J. Am. Chem. Soc. 2006, 128, 13368. (c) Wang, X.; List,
B. Angew. Chem., Int. Ed. 2008, 47, 1119. (d) Wanner, M. J.; van der
Haas, R. N. S.; de Cuba, K. R.; van Maarseveen, J. H.; Hiemstra, H. Angew.
Chem., Int. Ed. 2007, 46, 7485. For a related study using Brønsted acid
catalysis, see:(e) Storer, R. I.; Carrera, D. E.; Ni, Y.; MacMillan, D. W. C.
J. Am. Chem. Soc. 2006, 128, 84.
(6) (a) Uraguchi, D.; Terada, M. J. Am. Chem. Soc. 2004, 126, 5356. (b)
Akiyama, T.; Itoh, J.; Yokota, K.; Fuchibe, K. Angew. Chem., Int. Ed. 2004,
43, 1566.
(7) As early as ref 6b the limiting case transition state of fully ionized phosphate/
iminium ion pair was proposed, thereby foreshadowing the future develop-
ments in chiral counteranion chemistry.
(8) Reviews on chiral Brønsted acids: (a) Akiyama, T. Chem. ReV. 2007, 107,
5744. (b) Akiyama, T.; Itoh, J.; Fuchibe, K. AdV. Synth. Catal. 2006, 348,
999. (c) Connon, S. J. Angew. Chem., Int. Ed. 2006, 45, 3909.
(9) (a) Raheem, I. T.; Thiara, P. V.; Peterson, E. A.; Jacobsen, E. N. J. Am.
Chem. Soc. 2007, 129, 13404. (b) Raheem, I. T.; Thiara, P. V.; Jacobsen,
E. N. Org. Lett. 2008, 10, 1577. (c) Reisman, S. E.; Doyle, A. G.; Jacobsen,
E. N. J. Am. Chem. Soc. 2008, 130, 7198.
(10) For use of a stoichiometric chiral anion in an asymmetric Stevens
rearrangement: Gonc¸alves-Farbos, M-H.; Vial, L.; Lacour, J. Chem.
Commun. 2008, 829.
(11) Reviews on chiral phase transfer catalysis: (a) Ooi, T.; Maruoka, K. Angew.
Chem., Int. Ed. 2007, 46, 4222. (b) O’Donnell, M. J. In Catalytic
Asymmetric Synthesis, 2nd ed.; Ojima, I., Ed.; Wiley-VCH: New York,
2000; Chapter 10, pp 727-755. (c) O’Donnell, M. J. Acc. Chem. Res. 2004,
37, 506. (d) Lygo, B.; Andrews, B. I. Acc. Chem. Res. 2004, 37, 518.
(12) For selected recent examples of chiral cation phase transfer catalysis, see:
(a) Elsner, P.; Bernardi, L.; Salla, G. D.; Overgaard, J.; Jørgensen, K. A.
J. Am. Chem. Soc. 2008, 130, 4897. (b) Moss, T. A.; Fenwick, D. R.; Dixon,
D. J. J. Am. Chem. Soc. 2008, 130, 10076. (c) Wang, X.; Kitamura, M.;
Maruoka, K. J. Am. Chem. Soc. 2007, 129, 1038. (d) Poulsen, T. B.;
Bernardi, L.; Alema´n, J.; Overgaard, J.; Jørgensen, K. A. J. Am. Chem.
Soc. 2007, 129, 441.
(13) Many chiral phase transfer reactions go by an interfacial mechanism; this
is possible for our concept also but is not shown for simplicity.
(14) Carter, C.; Fletcher, S.; Nelson, A. Tetrahedron: Asymmetry 2003, 14, 1995.
(15) For selected studies of biologically active compounds bearing a trans-ꢀ-
aminoether motif, see: (a) Plouvier, B.; Beatch, G. N.; Jung, G. L.; Zolotoy,
A.; Sheng, T.; Clohs, L.; Barrett, T. D.; Fedida, D.; Wang, W. Q.; Zhu,
J. J.; Liu, Y.; Abraham, S.; Lynn, L.; Dong, Y.; Wall, R. A.; Walker,
M. J. A. J. Med. Chem. 2007, 50, 2818. (b) Rebollo, O.; del Olmo, E.;
Ruiz, G.; Lopez-Perez, J. L.; Gimenez, A.; San Feliciano, A. Bioorg. Med.
Chem. Lett. 2008, 18, 184. (c) Witty, D. R.; Bateson, J.; Hervieu, G. J.;
Al-Barazanji, K.; Jeffrey, P.; Hamprecht, D.; Haynes, A.; Johnson, C. N.;
Muir, A. I.; O’Hanlon, P. J.; Stemp, G.; Stevens, A. J.; Thewlis, K.;
Winborn, K. Y. Bioorg. Med. Chem. Lett. 2006, 16, 4872. (d) Takeuchi,
K.; Kohn, T. J.; Sall, D. J.; Denney, M. L.; McCowan, J. R.; Smith, G. F.;
Gifford-Moore, D. S. Bioorg. Med. Chem. Lett. 1999, 9, 759.
a Conditions: 15 mol % 2b, 2 equiv R2OH, 0.1 M in toluene, room temp,
12 h. Yields refer to isolated material; ee’s determined by chiral HPLC,
see Supporting Information.
products in very high yield and good ee (Scheme 2). Although the
reaction is initiated by protonation by the phosphoric acid, it is
clearly mechanistically distinct from chiral Brønsted catalyzed
reactions where a prochiral imine is activated by an acid. Since
the trichloroacetimidate starting material is chiral while the
intermediate episulfonium is meso, the ring opening must be
enantiodetermining. Therefore the enantioselectivity likely results
from an ion pair with the chiral anion rather than a hydrogen bond
to the electrophile.
In summary, we have developed two enantioselective ring
opening reactions of cationic intermediates that could not be readily
achieved using previously established methods of asymmetric
catalysis. In doing so we have expanded the range of chiral
counteranion-mediated reactions beyond iminium and oxocarbenium
based transformations. Furthermore, we have demonstrated that a
primary barrier to designing enantioselective reactions of more types
of cationic intermediates is the selective generation of the critical
chiral ion pair. Toward that end, we have shown here the success
of two methods: one based on a unique chiral anion phase transfer
catalytic cycle and the other on activation of trichloroacetimidates.
The flexibility of the two strategies should facilitate new reaction
development since either an organohalide or an alcohol (in the form
of the imidate) can serve as precursor.
Acknowledgment. We gratefully acknowledge Merck Research
Laboratories, Bristol-Myers Squibb, and Novartis for funding.
G.L.H. thanks the NSF for a graduate fellowship. T.K. thanks
Dainippon Sumitomo Pharma for funding and research opportunity.
(16) For asymmetric ring opening of protected aziridines with TMSN3, see:(a)
Fukuta, Y.; Mita, T.; Fukuda, N.; Kanai, M.; Shibasaki, M. J. Am. Chem.
Soc. 2006, 128, 6312. (b) Li, Z.; Ferna´ndez, M.; Jacobsen, E. N. Org. Lett.
1999, 1, 1611. With TMSCN: (c) Mita, T.; Fujimori, I.; Wada, R.; Wen,
J.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2005, 127, 11252.
(17) Recently a chiral phosphoric acid has also been used for desymmetrization
of meso-aziridines with TMSN3. In this case covalent activation of
benzoylated aziridine by silylated phosphate was proposed: Rowland, E. B.;
Rowland, G. B.; Rivera-Otero, E.; Antilla, J. C. J. Am. Chem. Soc. 2007,
129, 12084.
Supporting Information Available: Experimental procedures and
compound characterization data. This material is available free of charge
(18) Episulfonium ions are intermediates in numerous reactions but have not
been exploited in the context of asymmetric catalysis; for a review, see:
Fox, D. J.; House, D.; Warren, S. Angew. Chem., Int. Ed. 2002, 41, 2462.
References
(1) For a review on chiral anions, see: Lacour, J.; Hebbe-Viton, V. Chem.
Soc. ReV. 2003, 32, 373.
JA806431D
9
14986 J. AM. CHEM. SOC. VOL. 130, NO. 45, 2008